COVID-19 Assessment Agent
COVID-19 Assessment Agent
This AI agent guides patients through a structured symptom assessment for COVID-19 and other respiratory illnesses, determines risk level based on clinical criteria, and directs them to the appropriate level of care. With respiratory illness remaining one of the top reasons for emergency department visits and urgent care congestion, healthcare organizations need scalable triage tools that reduce unnecessary in-person visits while ensuring high-risk patients receive timely intervention. The CDC estimates that 40-70% of telehealth visits during respiratory surges involve conditions manageable through remote screening alone, making AI-driven symptom assessment a critical capacity multiplier for health systems.
COVID-19 Assessment Agent
Deploying an AI-powered respiratory symptom screening agent delivers measurable improvements in triage efficiency, patient access, and clinical resource utilization.
Emergency departments across the U.S. see over 130 million visits annually, and respiratory complaints consistently rank among the top five presenting conditions. Studies from health systems that implemented digital pre-screening during COVID found that 30-40% of patients who would have presented to the ED were safely triaged to home care or virtual visits instead. At an average ED visit cost of $2,200, diverting even 100 low-acuity patients per month saves a health system $264,000 annually while freeing beds and clinical staff for patients who genuinely need emergency care.
During respiratory illness surges, nurse hotlines experience call volumes 3-8x above baseline, with average hold times exceeding 30 minutes. An AI screening agent absorbs the straightforward symptom-check calls that constitute the majority of surge volume, allowing nurses to focus on complex clinical consultations. Health systems deploying chatbot-based triage during COVID reported handling 5-10x their normal call volume without adding temporary staff, avoiding significant overtime and agency nurse costs during the most operationally strained periods.
When every patient with a cough calls the same hotline, genuinely high-risk individuals wait in the same queue as low-acuity cases. AI-driven pre-screening identifies high-risk patients within minutes and routes them to clinical follow-up immediately, rather than after a 30-60 minute hold time. For conditions where early intervention significantly affects outcomes, particularly elderly and immunocompromised patients with respiratory infections, reducing time-to-triage from hours to minutes is a material clinical improvement, not just an operational one.
COVID-19 Assessment Agent
features
Designed for the operational demands of health systems managing high-volume respiratory illness triage during surges and steady-state.
The agent applies structured scoring logic based on established clinical criteria, not free-form AI interpretation. It evaluates symptom severity, duration, combination patterns, and risk-amplifying comorbidities like diabetes, cardiovascular disease, immunocompromised status, and age over 65. This rule-based approach produces consistent, auditable risk classifications that clinicians can trust as a first-pass triage layer. Unlike unstructured chatbot conversations, every assessment follows the same validated protocol.
During respiratory illness peaks, nurse hotlines and emergency departments become bottlenecked. A single AI screening agent handles unlimited concurrent assessments with zero wait time. During the 2020-2021 COVID surges, health systems that deployed digital triage tools reported diverting 30-40% of low-acuity patients away from emergency departments, preserving capacity for genuinely critical cases. The agent provides this same surge buffer on an ongoing basis for seasonal flu, RSV, and future respiratory outbreaks.
Respiratory illness outbreaks disproportionately affect communities with limited English proficiency, where language barriers delay care-seeking and increase emergency utilization. The Tars agent supports deployment in multiple languages, ensuring that non-English-speaking patients can complete symptom assessments in their preferred language. For health systems serving diverse populations, this capability directly addresses health equity goals and reduces the interpreter bottleneck that slows phone-based triage.
Every completed assessment generates structured data on symptom prevalence, geographic distribution, and risk factor patterns across your patient population. This aggregate data feeds population health dashboards that help infection control teams identify emerging clusters, track community transmission trends, and allocate testing and vaccination resources proactively. Rather than relying solely on lagging indicators like hospitalization rates, your organization gains near-real-time signal from the front door of patient engagement.
COVID-19 Assessment Agent
Get your respiratory illness screening agent live across patient touchpoints in three steps.
COVID-19 Assessment Agent
FAQs
The agent guides patients through a structured series of questions covering their current symptoms (fever, cough, shortness of breath, fatigue, loss of taste or smell), symptom duration and severity, recent exposure to confirmed cases, underlying health conditions, vaccination history, and recent travel. Based on their responses, it applies risk-scoring logic aligned with CDC and WHO screening criteria to classify the patient as low, moderate, or high risk. Each risk level receives tailored next-step guidance: home care instructions, telehealth scheduling, or emergency care routing.
Yes. Tars is HIPAA compliant, SOC 2 Type 2 certified, GDPR compliant, and ISO certified. All patient data collected during the screening assessment, including health symptoms, personal health information, and contact details, is encrypted in transit and at rest. Tars supports Business Associate Agreements for healthcare organizations that require them. The platform maintains the same security posture whether the agent is deployed on a hospital website, patient portal, or shared via SMS link.
Yes. The screening questions, risk-scoring criteria, and triage pathways are fully configurable through the Tars visual editor. When the CDC updates isolation guidance, when a new variant emerges with different symptom profiles, or when your organization revises its internal protocols, your team can update the agent in minutes without any coding or IT involvement. During the pandemic, organizations with configurable digital screening tools were able to adapt to rapidly shifting guidelines far faster than those relying on call center scripts.
No. The agent performs a structured pre-screening that triages patients by risk level and directs them to the appropriate care pathway. It does not diagnose COVID-19, influenza, RSV, or any other condition. High-risk patients are routed to clinical follow-up, moderate-risk patients to telehealth consultations, and low-risk patients to home monitoring with clear instructions on when to escalate. The agent is a capacity multiplier for your clinical team, not a replacement for clinical judgment.
Most organizations go live within days. You configure your screening protocol, risk thresholds, and triage routing in the Tars visual editor, then deploy via website widget, standalone link, or WhatsApp. No custom development or IT resources are required. During respiratory illness surges, speed of deployment is critical, and the ability to launch a fully functional screening agent in under a week gives health systems an immediate capacity buffer.
The agent captures structured assessment data including all symptom responses, risk scores, patient demographics, and contact information. This data integrates with your existing systems via 600+ connections including HubSpot, Salesforce, Google Sheets, and custom webhooks. For health systems needing direct EHR integration, Tars supports webhook-based data pushes that can feed into Epic, Cerner, or other EHR platforms through your integration layer. Assessment data can also be exported for population health analysis and reporting.
Yes. The Tars agent runs entirely in the browser or within messaging platforms like WhatsApp. No app download is required. Patients click a link from your website, a text message, or an email and immediately begin the screening assessment on their phone, tablet, or computer. This zero-friction access is critical during health crises when the goal is maximum population reach with minimum barriers to participation.
While initially developed for COVID-19, the underlying screening framework applies to any respiratory illness. Health systems use the same agent architecture for seasonal influenza, RSV surges, and emerging respiratory threats by updating the symptom criteria and triage protocols. Rather than building new triage infrastructure for each outbreak, you maintain a standing digital screening capability that scales instantly when respiratory illness volumes spike, whether that is a winter flu season or the next pandemic-level event.
Privacy & Security
At Tars, we take privacy and security very seriously. We are compliant with GDPR, ISO, SOC 2, and HIPAA.
Email - sales@hellotars.com
.png)
%201.png)
%201.png)
